EP 1435990 A1 20040714 - KAHALALIDE COMPOUNDS FOR USE IN CANCER THERAPY
Title (en)
KAHALALIDE COMPOUNDS FOR USE IN CANCER THERAPY
Title (de)
KAHALALID-VERBINDUNGEN ZUR VERWENDUNG IN DER KREBSTHERAPIE
Title (fr)
COMPOSES A BASE DE KAHALALIDE UTILISABLES EN THERAPIE ANTICANCEREUSE
Publication
Application
Priority
- GB 0204735 W 20021018
- GB 0104821 W 20011031
- GB 0222409 A 20020926
- US 34844901 P 20011019
Abstract (en)
[origin: WO03033012A1] Procedures for clinical trials of kahalalide compounds are provided, leading to new formulations of kahalalide compounds.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 38/12 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61P 35/00 (2006.01); A61K 9/19 (2006.01)
CPC (source: EP)
A61K 9/0019 (2013.01); A61K 38/12 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61P 35/00 (2017.12); A61K 9/19 (2013.01)
Citation (search report)
See references of WO 03033012A1
Citation (examination)
- EP 0610078 A1 19940810 - PHARMA MAR SA [ES]
- H. VAN DER GOOT: "Trends in Drug Research 2", 1998, ELSEVIER, article D.D.BREIMER: "Pharmacokinetics and metabolism in drug development: current and futrue strategies", pages: 85 - 90, XP009144291
- KERR D J ET AL: "Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: Non-randomised comparison of weekly versus four-weekly schedules - less pain, same gain", ANNALS OF ONCOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 11, no. 8, 1 August 2000 (2000-08-01), pages 947 - 955, XP019228602, ISSN: 1569-8041, DOI: DOI:10.1023/A:1008303229469
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03033012 A1 20030424; AU 2002334203 B2 20080124; AU 2002334203 C1 20081009; CA 2462639 A1 20030424; EP 1435990 A1 20040714
DOCDB simple family (application)
GB 0204735 W 20021018; AU 2002334203 A 20021018; CA 2462639 A 20021018; EP 02801430 A 20021018